Publications
Export 52 results:
Filters: Keyword is Disease Models, Animal [Clear All Filters]
, “Cell-type-specific role for nucleus accumbens neuroligin-2 in depression and stress susceptibility.”, Proc Natl Acad Sci U S A, vol. 115, no. 5, pp. 1111-1116, 2018.
, “Establishment of a repeated social defeat stress model in female mice.”, Sci Rep, vol. 7, no. 1, p. 12838, 2017.
, “Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.”, Neurobiol Dis, vol. 82, pp. 430-444, 2015.
, “Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome.”, Circulation, vol. 132, no. 4, pp. 230-40, 2015.
, “Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.”, Mol Ther, vol. 22, no. 3, pp. 498-510, 2014.
, “Overlap of food addiction and substance use disorders definitions: analysis of animal and human studies.”, Neuropharmacology, vol. 85, pp. 81-90, 2014.
, “Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1.”, Hum Mol Genet, vol. 22, no. 19, pp. 3947-59, 2013.
, “Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival.”, Neuron, vol. 80, no. 1, pp. 80-96, 2013.
, “Reactive glia in the injured brain acquire stem cell properties in response to sonic hedgehog. [corrected].”, Cell Stem Cell, vol. 12, no. 4, pp. 426-39, 2013.
, “Ablation of proliferating cells in the CNS exacerbates motor neuron disease caused by mutant superoxide dismutase.”, PLoS One, vol. 7, no. 4, p. e34932, 2012.
, “Abnormal regenerative responses and impaired axonal outgrowth after nerve crush in TDP-43 transgenic mouse models of amyotrophic lateral sclerosis.”, J Neurosci, vol. 32, no. 50, pp. 18186-95, 2012.
, “Methylene blue administration fails to confer neuroprotection in two amyotrophic lateral sclerosis mouse models.”, Neuroscience, vol. 209, pp. 136-43, 2012.
, “Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.”, J Vis Exp, no. 69, 2012.
, “Real-time imaging after cerebral ischemia: model systems for visualization of inflammation and neuronal repair.”, Methods Enzymol, vol. 506, pp. 117-33, 2012.
, “ALS pathogenesis: recent insights from genetics and mouse models.”, Prog Neuropsychopharmacol Biol Psychiatry, vol. 35, no. 2, pp. 363-9, 2011.
, “Animal models of human anxiety disorders: reappraisal from a developmental psychopathology vantage point.”, Pediatr Res, vol. 69, no. 5 Pt 2, p. 77R-84R, 2011.
, “Gigaxonin mutation analysis in patients with NIFID.”, Neurobiol Aging, vol. 32, no. 8, pp. 1528-9, 2011.
, “Model system for live imaging of neuronal responses to injury and repair.”, Mol Imaging, vol. 10, no. 6, pp. 434-45, 2011.
, “Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.”, Brain, vol. 134, no. Pt 9, pp. 2610-26, 2011.
, “Distinct biochemical signatures characterize peripherin isoform expression in both traumatic neuronal injury and motor neuron disease.”, J Neurochem, vol. 114, no. 4, pp. 1177-92, 2010.
, “Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice.”, J Neuropathol Exp Neurol, vol. 69, no. 10, pp. 1044-56, 2010.
, “Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia.”, Ann Neurol, vol. 68, no. 5, pp. 619-28, 2010.
, “Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS.”, J Neurochem, vol. 115, no. 5, pp. 1102-11, 2010.
, “Reversal of neuropathy phenotypes in conditional mouse model of Charcot-Marie-Tooth disease type 2E.”, Hum Mol Genet, vol. 19, no. 13, pp. 2616-29, 2010.
, “Wild-type human SOD1 overexpression does not accelerate motor neuron disease in mice expressing murine Sod1 G86R.”, Neurobiol Dis, vol. 40, no. 1, pp. 245-50, 2010.
